TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 57 filers reported holding TALARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,240,623 | -7.6% | 2,932,606 | 0.0% | 10.94% | +16.8% |
Q2 2023 | $8,915,122 | +61.7% | 2,932,606 | 0.0% | 9.37% | +40.4% |
Q1 2023 | $5,513,299 | +84.3% | 2,932,606 | 0.0% | 6.67% | +68.6% |
Q4 2022 | $2,991,258 | -61.2% | 2,932,606 | 0.0% | 3.96% | -64.7% |
Q3 2022 | $7,713,000 | -41.7% | 2,932,606 | 0.0% | 11.20% | -39.0% |
Q2 2022 | $13,226,000 | -54.2% | 2,932,606 | 0.0% | 18.36% | -32.3% |
Q1 2022 | $28,857,000 | -35.6% | 2,932,606 | 0.0% | 27.11% | +31.4% |
Q4 2021 | $44,840,000 | – | 2,932,606 | – | 20.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 682,923 | $10,032,000 | 1.61% |
SECTORAL ASSET MANAGEMENT INC | 711,000 | $10,445,000 | 0.84% |
Logos Global Management LP | 507,923 | $7,461,000 | 0.63% |
Artal Group S.A. | 2,064,262 | $30,324,000 | 0.62% |
Cormorant Asset Management, LP | 1,215,847 | $17,264,000 | 0.59% |
Eventide Asset Management | 1,561,092 | $22,411,000 | 0.30% |
Blackstone Inc. | 8,089,315 | $118,832,000 | 0.27% |
Avidity Partners Management LP | 436,363 | $6,410,000 | 0.17% |
VIKING GLOBAL INVESTORS LP | 3,289,617 | $48,324,000 | 0.15% |
HHLR ADVISORS, LTD. | 853,344 | $12,536,000 | 0.13% |